Recro Pharma (REPH) Moves to Buy: Rationale Behind the Upgrade Posted byZacks Equity Research September 16, 2021 Leave a comment on Recro Pharma (REPH) Moves to Buy: Rationale Behind the Upgrade Recro Pharma (REPH) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company’s earnings prospects. This might drive t…